TIOTROPIU MYLAN 18mcg capsule inhalation powder medication leaflet

A10BH02 tiotropium • Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Dipeptidyl peptidase 4 (DDP-4) inhibitors

Tiotropium is a bronchodilator used for the treatment of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It works by blocking muscarinic receptors in the airways, relaxing the muscles and making breathing easier.

The medication is administered via inhaler, usually once daily, as directed by a doctor. It is used for long-term control of symptoms and not for quick relief of breathing crises.

Patients should strictly follow the instructions for using the inhaler and inform their doctor of any unusual symptoms. It is important not to exceed the recommended dose.

Side effects may include dry mouth, cough, throat irritation, and, in rare cases, severe allergic reactions or breathing difficulties. Patients should be informed of these risks before starting treatment.

General data about TIOTROPIU MYLAN 18mcg

Substance: tiotropium

Date of last drug list: 01-12-2023

Commercial code: W69857003

Concentration: 18mcg

Pharmaceutical form: capsule inhalation powder

Quantity: 90

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: FERRER INTERNACIONAL, S.A. - SPANIA

Holder: VIATRIS LIMITED - IRLANDA

Number: 11370/2019/03

Shelf life: 2 years

Pharmaceutical forms available for tiotropium

Concentrations available for tiotropium

10mcg, 18mcg, 2.5mcg

Other substances similar to tiotropium

Combinations with other substances